Combined gemcitabine and cisplatin in the treatment of advanced non - small cell lung cancer 健擇聯(lián)合順鉑治療晚期非小細胞肺癌的臨床研究
Attenuation of shen fu injection on taxol plus cisplatin in treating non - small cell lung cancer 參附注射液對健擇聯(lián)合順鉑治療非小細胞肺癌的減毒作用
Research on gemcitabine combined cisplatin peritoneal perfusion in the treatment of primary hepatocellular carcinoma 健擇聯(lián)合順鉑治療老年晚期非小細胞肺癌患者的臨床療效觀察
Clinical study of therapeutic efficacy of gemcitabined combined with cisplatin for advanced non - small cell lung cancer in elderly patients 健擇聯(lián)合腹腔灌注順鉑治療原發(fā)性肝細胞癌的臨床研究
Mohiuddin m , rosato f , barbot d , et al . long - term results of combined modality treatment with - 125 implantation for carcinoma of the pancreas . int j radiat oncol biol phys , 1992 , 23 ( 2 ) : 305 - 311 李文靖,韓偉,陳軍,等.放射性125i粒子植入聯(lián)合健擇和順鉑動脈灌注治療晚期胰腺癌.廣西醫(yī)學, 2004 , 26 ( 10 ) : 1455
While both gemcitabine - docetaxel and gemcitabine - vinorelbine are regimens with significant activity and acceptable toxicity they require larger randomized trials before they can be said to be standard of care 雖然健擇泰索帝和健擇諾維本均為具有顯著活性和可接受毒性的方案,在它們可被稱為標準治療方案之前還需要進行更大規(guī)模的隨機臨床研究以評估其療效和不良反應。